Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2016
published in
- Ophthalmology Journal
has subject area
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors
- Bevacizumab
- Cohort Studies
- Databases, Factual
- Diabetic Retinopathy
- Drug Utilization
- Female
- Humans
- Insurance, Health
- Intravitreal Injections
- Macular Degeneration
- Male
- Medicare Part C
- Middle Aged
- Ophthalmology
- Private Sector
- Ranibizumab
- Receptors, Vascular Endothelial Growth Factor
- Recombinant Fusion Proteins
- Retinal Vein Occlusion
- Retrospective Studies
- United States
- Vascular Endothelial Growth Factor A
- Young Adult